跳至主要内容
临床试验/CTRI/2017/12/010995
CTRI/2017/12/010995已完成2 期

A Clinical Study to Evaluate the Efficacy and Safety of Marham Kharish Jadeed in the Management of Quba (Tinea Corporis) - TMKJ

Central Research Institute of Unani Medicine0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients having Quba (Tinea corporis) with the following signs and symptom:
  • c.Scaling of lesion
  • d.Central clearing with peripheral raised margins
  • 2.Patients with a mycological diagnosis of Tinea Corporis confirmed by microscopic KOH wet mount

排除标准

  • 1.All other clinical types of tinea infections
  • 2.Patients with secondary bacterial infections/ Diabetes Mellitus
  • 3.Pregnant and lactating women
  • 4.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
  • 5.Known cases of Immunocompromised states (HIV/ AIDS, etc.)
  • 6.History of hypersensitivity to Terbinafine and Marham Kharish Jadeed
  • 7.Patients using the following medications:
  • 8.Topical antifungal agent/ topical corticosteroids in treatment area within 30 days of baseline visit
  • 9.Systemic anti-fungals within 8 weeks of baseline visit (8 months for oral Terbinafine)
  • 10.Systemic corticosteroids within 30 days of baseline visit

研究者

相似试验